$MBOT
Microbot Medical Inc.

2015 Q3 Form 10-Q Financial Statement

#000119312515280997 Filed on August 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q2
Revenue $37.03K $30.13K $23.00K
YoY Change -54.84% 31.0% -30.3%
Cost Of Revenue $78.10K
YoY Change 0.68%
Gross Profit $164.1K
YoY Change -19.6%
Gross Profit Margin 713.51%
Selling, General & Admin $2.310M $2.060M $2.176M
YoY Change 11.53% -5.32% 37.58%
% of Gross Profit 1325.84%
Research & Development $7.720M $7.239M $5.839M
YoY Change 75.57% 23.97% 21.53%
% of Gross Profit 3558.24%
Depreciation & Amortization $274.0K $255.0K $330.0K
YoY Change 11.38% -22.73% 43.48%
% of Gross Profit 201.09%
Operating Expenses $10.02M $9.303M $7.983M
YoY Change 55.14% 16.53% 30.21%
Operating Profit -$9.988M -$9.273M -$7.960M
YoY Change 56.56% 16.5% 27.94%
Interest Expense $106.8K $146.3K $343.2K
YoY Change -65.68% -57.38% -12.63%
% of Operating Profit
Other Income/Expense, Net $345.3K $810.9K -$4.011M
YoY Change -90.82% -120.21% -1237.67%
Pretax Income -$9.640M -$8.460M -$11.95M
YoY Change 267.94% -29.21% 103.58%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.643M -$8.462M -$12.12M
YoY Change 249.73% -30.16% 106.44%
Net Earnings / Revenue -26040.09% -28083.08% -52674.89%
Basic Earnings Per Share
Diluted Earnings Per Share -$137.7M -$141.0M -$403.0M
COMMON SHARES
Basic Shares Outstanding 108.5M shares 105.1M shares 55.51M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.19M $29.93M $17.85M
YoY Change -34.21% 67.68% -26.18%
Cash & Equivalents $21.19M $29.93M $17.85M
Short-Term Investments
Other Short-Term Assets $24.19K $25.17K $107.4K
YoY Change -39.53% -76.56% -84.75%
Inventory
Prepaid Expenses $917.8K $874.3K $690.2K
Receivables $2.625K $2.743K $88.04K
Other Receivables $140.0K $190.0K $130.0K
Total Short-Term Assets $22.27M $31.03M $18.90M
YoY Change -33.64% 64.14% -27.29%
LONG-TERM ASSETS
Property, Plant & Equipment $5.441M $5.266M $5.141M
YoY Change 6.15% 2.43% 48.99%
Goodwill $2.208M
YoY Change 19.01%
Intangibles $294.3K $315.2K $1.727M
YoY Change -81.42% -81.75% 4.39%
Long-Term Investments
YoY Change
Other Assets $373.7K $373.7K $373.7K
YoY Change -6.49% 0.0% -64.54%
Total Long-Term Assets $6.109M $5.955M $9.458M
YoY Change -33.65% -37.04% 17.39%
TOTAL ASSETS
Total Short-Term Assets $22.27M $31.03M $18.90M
Total Long-Term Assets $6.109M $5.955M $9.458M
Total Assets $28.38M $36.98M $28.36M
YoY Change -33.64% 30.4% -16.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.392M $1.377M $1.706M
YoY Change 14.36% -19.3% -43.54%
Accrued Expenses $5.627M $4.623M $2.613M
YoY Change 115.56% 76.91% 36.26%
Deferred Revenue
YoY Change
Short-Term Debt $2.450M $3.470M $3.830M
YoY Change -37.5% -9.4% 46.74%
Long-Term Debt Due $20.00K $20.00K $17.92K
YoY Change 0.0% 11.63% -91.62%
Total Short-Term Liabilities $9.635M $9.619M $8.296M
YoY Change 22.44% 15.95% 6.07%
LONG-TERM LIABILITIES
Long-Term Debt $8.930M $8.940M $11.13M
YoY Change -25.95% -19.68% 63500.0%
Other Long-Term Liabilities $399.4K $3.170M $11.48M
YoY Change -94.37% -72.39% 9.65%
Total Long-Term Liabilities $399.4K $12.11M $22.61M
YoY Change -97.91% -46.44% 129100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.635M $9.619M $8.296M
Total Long-Term Liabilities $399.4K $12.11M $22.61M
Total Liabilities $21.27M $21.72M $30.90M
YoY Change -21.28% -29.71% 22.18%
SHAREHOLDERS EQUITY
Retained Earnings -$447.7M -$438.1M -$407.3M
YoY Change 9.2% 7.57% 9.08%
Common Stock $454.8M $453.3M $404.4M
YoY Change 6.86% 12.1% 5.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.109M $15.26M -$2.543M
YoY Change
Total Liabilities & Shareholders Equity $28.38M $36.98M $28.36M
YoY Change -33.64% 30.4% -16.72%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$9.643M -$8.462M -$12.12M
YoY Change 249.73% -30.16% 106.44%
Depreciation, Depletion And Amortization $274.0K $255.0K $330.0K
YoY Change 11.38% -22.73% 43.48%
Cash From Operating Activities -$7.270M -$7.570M -$7.770M
YoY Change 8.83% -2.57% 105.56%
INVESTING ACTIVITIES
Capital Expenditures -$450.0K -$340.0K -$130.0K
YoY Change 87.5% 161.54% -93.81%
Acquisitions
YoY Change
Other Investing Activities $20.00K $0.00
YoY Change
Cash From Investing Activities -$430.0K -$340.0K -$130.0K
YoY Change 79.17% 161.54% -102.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.050M 23.68M -720.0K
YoY Change -104.93% -3388.89% -105.54%
NET CHANGE
Cash From Operating Activities -7.270M -7.570M -7.770M
Cash From Investing Activities -430.0K -340.0K -130.0K
Cash From Financing Activities -1.050M 23.68M -720.0K
Net Change In Cash -8.750M 15.77M -8.620M
YoY Change -160.89% -282.95% -155.58%
FREE CASH FLOW
Cash From Operating Activities -$7.270M -$7.570M -$7.770M
Capital Expenditures -$450.0K -$340.0K -$130.0K
Free Cash Flow -$6.820M -$7.230M -$7.640M
YoY Change 5.9% -5.37% 354.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.85
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
108516928 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30585424
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68729774 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68729774 shares
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
425389693
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
5870773
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
85925
CY2014Q4 us-gaap Loans Payable Current
LoansPayableCurrent
4686388
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1734214
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16826
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1818831
CY2014Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
10334029
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4869710
CY2014Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
22082
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
159466
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-420271608
CY2014Q4 us-gaap Liabilities
Liabilities
26555986
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32426759
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
46084
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
687298
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11497871
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
65390
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
20191
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
9230
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
373717
CY2014Q4 us-gaap Assets
Assets
32426759
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
356889
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5186958
CY2014Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
24987603
CY2014Q4 us-gaap Assets Current
AssetsCurrent
26507971
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
64928
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1224
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1017726
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24987603
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24987603
CY2014Q4 us-gaap Other Receivables
OtherReceivables
256166
CY2014Q4 stem Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0
CY2014Q4 stem Deposits And Other Long Term Liabilities
DepositsAndOtherLongTermLiabilities
1250007
CY2014Q4 stem Fair Value Of Warrant Liability
FairValueOfWarrantLiability
1684551
CY2014Q4 stem Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
0
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17847097
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
276229 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.66
CY2015Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2765229 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.49
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108133332 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108133332 shares
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
452212600
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
15259710
CY2015Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
111656
CY2015Q2 us-gaap Loans Payable Current
LoansPayableCurrent
3466377
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16826
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1376605
CY2015Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1684717
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
373717
CY2015Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
8916641
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4622722
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-438084023
CY2015Q2 us-gaap Liabilities
Liabilities
21721393
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36981103
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
37671
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
1081333
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9619118
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
49800
CY2015Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
24932
CY2015Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
20362
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9636000
CY2015Q2 us-gaap Assets
Assets
36981103
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
54923
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
75496
CY2015Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
315166
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2743
CY2015Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
8763
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
83000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5266367
CY2015Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
29929140
CY2015Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
100000
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
26594
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
27978
CY2015Q2 us-gaap Assets Current
AssetsCurrent
31025853
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
25166
CY2015Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
874303
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29929140
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
27978
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
29929140
CY2015Q2 us-gaap Other Receivables
OtherReceivables
185738
CY2015Q2 stem Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0
CY2015Q2 stem Deposits And Other Long Term Liabilities
DepositsAndOtherLongTermLiabilities
399370
CY2015Q2 stem Fair Value Of Warrant Liability
FairValueOfWarrantLiability
1043514
CY2015Q2 stem Carrying Value Of Purchased Loans
CarryingValueOfPurchasedLoans
9512000
CY2015Q2 stem Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
0
CY2015Q2 stem Fair Value Allocated To Warrant
FairValueAllocatedToWarrant
388000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17720536 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14277185
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55529818 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.36
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
10466
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
362873
us-gaap Net Income Loss
NetIncomeLoss
-19735480
us-gaap Interest Paid
InterestPaid
272478
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
170663
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
316350
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10469001
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1898442
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
279084
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-583429
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1034766
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4379669
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
3289
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-362873
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3820264
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
499333
us-gaap Operating Income Loss
OperatingIncomeLoss
-14801607
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-17207
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-202217
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-202217
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30724
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4731656
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23693
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-5671
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2007457
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-366487
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
110569
us-gaap Investment Income Interest
InvestmentIncomeInterest
3874
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-19533263
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19624911
us-gaap Share Based Compensation
ShareBasedCompensation
1034766
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3981094
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-31763
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12741616
us-gaap Operating Expenses
OperatingExpenses
14848670
us-gaap Interest Expense
InterestExpense
723712
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
671562
stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
47063
stem Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
6797
stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.02
stem Amortization Of Debt Discount And Debt Issuance Costs
AmortizationOfDebtDiscountAndDebtIssuanceCosts
136873
stem Comprehensive Income Loss From Discontinued Operations
ComprehensiveIncomeLossFromDiscontinuedOperations
-91648
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
66006116 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000883975
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16484500
dei Entity Registrant Name
EntityRegistrantName
STEMCELLS INC
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Reclassifications</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Certain reclassifications have been made to the prior year financial statements in order to conform to the current year&#x2019;s presentation.</p> </div>
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, assumptions and estimates that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> Significant estimates include the following:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the grant date fair value of stock-based awards recognized as compensation expense (see Note 5, &#x201C;Stock-Based Compensation&#x201D;); and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the fair value of warrants recorded as a liability (see Note 8, &#x201C;Warrant Liability&#x201D;).</td> </tr> </table> </div>
dei Trading Symbol
TradingSymbol
STEM
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
82277137 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.22
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
11014
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
556313
us-gaap Net Income Loss
NetIncomeLoss
-17812415
us-gaap Interest Paid
InterestPaid
143036
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-182581
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
386488
us-gaap Operating Income Loss
OperatingIncomeLoss
-18232973
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
107611
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
420558
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-153026
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
148898
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2698054
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-69251
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15590
us-gaap Investment Income Interest
InvestmentIncomeInterest
3533
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
9900000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
23617
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-17812415
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17828005
us-gaap Share Based Compensation
ShareBasedCompensation
2660468
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-641037
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8413
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4955307
us-gaap Operating Expenses
OperatingExpenses
18284101
us-gaap Interest Expense
InterestExpense
331623
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13531176
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21847407
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24942963
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
148713
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1536194
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2660468
us-gaap Debt Issuance Costs
DebtIssuanceCosts
117000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4752925
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-13770
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-407600
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
545698
stem Debt Instrument Amortized Discount Percentage
DebtInstrumentAmortizedDiscountPercentage
0.090 pure
stem Maturity Period Of Long Term Debt
MaturityPeriodOfLongTermDebt
2014-08
stem Common Stock Per Unit
CommonStockPerUnit
1
stem Debt Instrument Period During Which Loan Is Subject To Interest Only Payments
DebtInstrumentPeriodDuringWhichLoanIsSubjectToInterestOnlyPayments
P6M
stem Continuing Value Of Patent
ContinuingValueOfPatent
0
stem Restricted Stock Unit Vest Description
RestrictedStockUnitVestDescription
These stock awards are performance based and vest on achievement of predefined milestones.
stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
51128
stem Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-23766
stem Warrants Issued Per Unit
WarrantsIssuedPerUnit
1
stem Number Of Share Based Equity Incentive Plan
NumberOfShareBasedEquityIncentivePlan
2 Incentive_Plan
stem Debt Instrument Period During Which Loan Is Subject To Principal And Interest Payments
DebtInstrumentPeriodDuringWhichLoanIsSubjectToPrincipalAndInterestPayments
P30M
stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.03
stem Amortization Of Debt Discount And Debt Issuance Costs
AmortizationOfDebtDiscountAndDebtIssuanceCosts
75199
stem Loan Fees
LoanFees
1000000
stem Comprehensive Income Loss From Discontinued Operations
ComprehensiveIncomeLossFromDiscontinuedOperations
-15590
stem Cash And Cash Equivalents Maturity Period
CashAndCashEquivalentsMaturityPeriod
P90D
stem Number Of Patents Expired
NumberOfPatentsExpired
4 Claim
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
35715000 shares
CY2015Q2 stem Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2015Q2 stem Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
25000000
CY2006Q3 stem Number Of Patients Violate Claims
NumberOfPatientsViolateClaims
4 Claim
CY2008Q2 stem Number Of Patients Violate Claims
NumberOfPatientsViolateClaims
2 Claim
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000000
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
149000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55711717 shares
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.22
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-12115224
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7959504
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-144489
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-144489
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15226
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4011231
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
97109
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1689
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11970735
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12018115
CY2014Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3654470
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
7982983
CY2014Q2 us-gaap Interest Expense
InterestExpense
343224
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5839327
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
513660
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2143656
CY2014Q2 stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
23479
CY2014Q2 stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.01
CY2014Q2 stem Comprehensive Income Loss From Discontinued Operations
ComprehensiveIncomeLossFromDiscontinuedOperations
-47380
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1000 shares
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
32.40
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.70
CY2015Q2 stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
30131
CY2015Q2 stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.01
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2490000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95190823 shares
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0
CY2015Q2 stem Comprehensive Income Loss From Discontinued Operations
ComprehensiveIncomeLossFromDiscontinuedOperations
16852
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.09
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-8461714
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9272583
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33370
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
810869
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16852
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2139
CY2015Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8461714
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8444862
CY2015Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-988367
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
9302714
CY2015Q2 us-gaap Interest Expense
InterestExpense
146267
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7238985
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1351574
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2063729
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21000

Files In Submission

Name View Source Status
0001193125-15-280997-index-headers.html Edgar Link pending
0001193125-15-280997-index.html Edgar Link pending
0001193125-15-280997.txt Edgar Link pending
0001193125-15-280997-xbrl.zip Edgar Link pending
d47635d10q.htm Edgar Link pending
d47635dex311.htm Edgar Link pending
d47635dex312.htm Edgar Link pending
d47635dex321.htm Edgar Link pending
d47635dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stem-20150630.xml Edgar Link completed
stem-20150630.xsd Edgar Link pending
stem-20150630_cal.xml Edgar Link unprocessable
stem-20150630_def.xml Edgar Link unprocessable
stem-20150630_lab.xml Edgar Link unprocessable
stem-20150630_pre.xml Edgar Link unprocessable